4
Changes in Ownership
Vaxcyte, Inc. Filed Acc 0001649094-24-000091
CHIEF EXECUTIVE OFFICER sold 15,000 shares at an average $106.82 ($1,602,252)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| PICKERING GRANT CHIEF EXECUTIVE OFFICER | 2024-11-01 | Sale 10b5-1 | −9,955 | $106.35 | $1,058,714 | 440,264 | D |
| PICKERING GRANT CHIEF EXECUTIVE OFFICER | 2024-11-01 | Sale 10b5-1 | −3,312 | $107.34 | $355,507 | 436,952 | D |
| PICKERING GRANT CHIEF EXECUTIVE OFFICER | 2024-11-01 | Sale 10b5-1 | −1,733 | $108.50 | $188,031 | 435,219 | D |
| Open-market sales · 15,000 sh · avg $106.82 · $1,602,252 | |||||||
Loading xslF345X05/wk-form4_1730763998.xml…